Beijing Monolith Investment Management Center (LLP) focuses and invests in the medical treatment and big health industry including wholly-owned acquisition, equity participation, holding and custody. We follow the development trend of China's medical market, integrates domestic and foreign market resources, and mainly invests in innovative and growing companies in the medical treatment and medical device niche markets. It devotes to becoming a value finder and integrator in China's medical treatment and big health field and promoting the integration of domestic medical treatment and health resources and the development of the market.
1.Investment on Medical InstitutionsThe medical institutions currently invested by us cover national comprehensive tertiary B-class hospitals, tertiary integrated traditional Chinese and Western medicine hospitals and second-class A hospitals, and medical institutions integrating medical treatment, prevention, rehabilitation and teaching, which are located in Nanjing, Jiangsu, Chengdu, Sichuan, Nanchong, Sichuan, and Zhumadian, Henan. On the basis of the existing hospital operation, we make full use of Internet resources and strive to build an Internet hospital. By means of surgical medical assistance systems, first-hand medical information of hospitals can be obtained, Internet, data analysis and artificial intelligence (AI) are combined and foreign online computer-aided medical and medical support systems are introduced by learning their experiences and carry out cooperation, which finally provides patients with good domestic and foreign medical resources.
2.Medical Devices
Our currently invested medical projects focus on the detection, monitoring and treatment of diabetes and medical devices for the treatment of diabetes complications. Based on successful experiences in the application of existing insulin pumps, the company integrates various resources related to continuous glucose monitoring (CGM) and algorithms at home and abroad to initially form a closed-loop of insulin pump+CGM+algorithm and possess the capacity of developing artificial pancreas.
The company has invested and operated a medical device company in Beijing which is specialized in the research and development, production, sales and service of diabetes-related products. In Zhengzhou of Henan Province, we have also invested and operated a technology-based enterprise specializing in the development and production of high-tech medical devices and development of medical software, and a high-tech enterprise specializing in the production, development and sales of category II and category III medical devices in the fields of endocrinology, anesthesia and respiration.
3.Health Management
We have attached great importance to the field of health management and established high-end health examination centers in Beijing and Dalian. The center provides a full range of medical services such as specialist treatment, chronic disease monitoring and management, telemedicine and women's health.
1.Investment on Medical InstitutionsThe medical institutions currently invested by us cover national comprehensive tertiary B-class hospitals, tertiary integrated traditional Chinese and Western medicine hospitals and second-class A hospitals, and medical institutions integrating medical treatment, prevention, rehabilitation and teaching, which are located in Nanjing, Jiangsu, Chengdu, Sichuan, Nanchong, Sichuan, and Zhumadian, Henan. On the basis of the existing hospital operation, we make full use of Internet resources and strive to build an Internet hospital. By means of surgical medical assistance systems, first-hand medical information of hospitals can be obtained, Internet, data analysis and artificial intelligence (AI) are combined and foreign online computer-aided medical and medical support systems are introduced by learning their experiences and carry out cooperation, which finally provides patients with good domestic and foreign medical resources.
2.Medical Devices
Our currently invested medical projects focus on the detection, monitoring and treatment of diabetes and medical devices for the treatment of diabetes complications. Based on successful experiences in the application of existing insulin pumps, the company integrates various resources related to continuous glucose monitoring (CGM) and algorithms at home and abroad to initially form a closed-loop of insulin pump+CGM+algorithm and possess the capacity of developing artificial pancreas.
The company has invested and operated a medical device company in Beijing which is specialized in the research and development, production, sales and service of diabetes-related products. In Zhengzhou of Henan Province, we have also invested and operated a technology-based enterprise specializing in the development and production of high-tech medical devices and development of medical software, and a high-tech enterprise specializing in the production, development and sales of category II and category III medical devices in the fields of endocrinology, anesthesia and respiration.
3.Health Management
We have attached great importance to the field of health management and established high-end health examination centers in Beijing and Dalian. The center provides a full range of medical services such as specialist treatment, chronic disease monitoring and management, telemedicine and women's health.
